[Featured Stock] Moon Orders Review of Russian Vaccine... IDIS Hits Upper Limit

[Asia Economy Reporter Ji Yeon-jin] Related stocks are soaring on the 22nd as President Moon Jae-in has ordered a review of the possibility of introducing Russia's COVID-19 vaccine, Sputnik V.

Idis started rising immediately after the market opened and reached the price limit (29.96%) during the session, closing at 590 won. Its affiliate, Etron, is trading at 1,040 won, up 25.91%.

These two stocks are considered related stocks as they invested in Korea Corus, which has been contract manufacturing (CMO) Russia's Sputnik V domestically since December last year.

Earlier, President Moon reportedly instructed to review the possibility of introducing the Sputnik V vaccine. The Sputnik V vaccine was developed and approved by Russia in August last year, making it the world's first.